Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial
暂无分享,去创建一个
M. Brandi | R. Bouillon | J. González‐Macías | J. del Pino-Montes | J. Pérez-Castrillón | B. Galarraga | J. M. Quesada-Gomez | A. Dueñas‐Laita | E. Jódar | C. Gómez-Alonso | S. Chinchilla | N. Fernández-Hernando | G. Hernández-Herrero | F. Castro | L. López | José Manuel Olmos Martínez | M. R. A. Expósito | P. Arranz-Gutiérrez | A. Dueñas-Laita
[1] R. Bouillon,et al. “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study” , 2020, The Journal of Steroid Biochemistry and Molecular Biology.
[2] Free vitamin D correlate better with bone mineral density and thoracolumbar junction osteoporotic vertebral fractures than serum vitamin D , 2020, BMC Musculoskeletal Disorders.
[3] C. Annweiler,et al. Vitamin D testing: advantages and limits of the current assays , 2020, European Journal of Clinical Nutrition.
[4] M. Tuveri,et al. Effects of alendronate and calcifediol compared to alendronate and cholecalciferol in osteoporotic patients. , 2019, Minerva endocrinologica.
[5] P. Mecocci,et al. Effects of Weekly Supplementation of Cholecalciferol and Calcifediol Among the Oldest-Old People: Findings From a Randomized Pragmatic Clinical Trial , 2019, Nutrients.
[6] D. Bikle,et al. Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions , 2019, Front. Endocrinol..
[7] K. Cashman. Vitamin D Deficiency: Defining, Prevalence, Causes, and Strategies of Addressing , 2019, Calcified Tissue International.
[8] John H. White,et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions , 2018, Endocrine reviews.
[9] Geert Carmeliet,et al. Vitamin D insufficiency: Definition, diagnosis and management. , 2018, Best practice & research. Clinical endocrinology & metabolism.
[10] R. Bouillon,et al. Is calcifediol better than cholecalciferol for vitamin D supplementation? , 2018, Osteoporosis International.
[11] M. Krasowski,et al. Vitamin D Toxicity: A 16-Year Retrospective Study at an Academic Medical Center , 2018, Laboratory medicine.
[12] Vladyslav Povoroznyuk,et al. Vitamin D supplementation guidelines , 2018, The Journal of Steroid Biochemistry and Molecular Biology.
[13] J. Hernández,et al. Calcifediol mensual frente a calcifediol quincenal en el tratamiento de pacientes osteoporóticos. Estudio en la vida real , 2018, Revista de Osteoporosis y Metabolismo Mineral.
[14] D. Bikle,et al. Current Controversies: Are Free Vitamin Metabolite Levels a More Accurate Assessment of Vitamin D Status than Total Levels? , 2017, Endocrinology and metabolism clinics of North America.
[15] K. Cashman,et al. 25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population. , 2017, Advances in nutrition.
[16] L. Rejnmark,et al. Current Assays to Determine Free 25-Hydroxyvitamin D in Serum. , 2017, Journal of AOAC International.
[17] N. Heureux,et al. A Direct Assay for Measuring Free 25-Hydroxyvitamin D. , 2017, Journal of AOAC International.
[18] H. Bischoff-Ferrari,et al. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens , 2017, Osteoporosis International.
[19] A. Chérif,et al. Why don’t serum vitamin D concentrations associate with BMD by DXA? A case of being ‘bound’ to the wrong assay? Implications for vitamin D screening , 2017, British Journal of Sports Medicine.
[20] J. Adams,et al. Effects of Cholecalciferol vs Calcifediol on Total and Free 25-Hydroxyvitamin D and Parathyroid Hormone , 2017, The Journal of clinical endocrinology and metabolism.
[21] V. Gudnason,et al. Imminent risk of fracture after fracture , 2017, Osteoporosis International.
[22] J. M. Quesada-Gomez,et al. Vitamin D3 and calcidiol are not equipotent , 2016, The Journal of Steroid Biochemistry and Molecular Biology.
[23] X. Nogués,et al. Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014) , 2015 .
[24] J. Reginster,et al. The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) , 2015, Endocrine.
[25] P. Lips,et al. Thresholds for Serum 25(OH)D Concentrations With Respect to Different Outcomes. , 2015, The Journal of clinical endocrinology and metabolism.
[26] E. Orwoll,et al. Vitamin D and DBP: The free hormone hypothesis revisited , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[27] R. Francis,et al. National Osteoporosis Society vitamin D guideline summary. , 2014, Age and ageing.
[28] E. M. Lewiecki,et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis International.
[29] H. Bischoff-Ferrari,et al. Calcifediol versus vitamin D3 effects on gait speed and trunk sway in young postmenopausal women: a double-blind randomized controlled trial , 2014, Osteoporosis International.
[30] M. Brandi,et al. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent , 2013, Current medical research and opinion.
[31] R. Herr,et al. A systematic review of vitamin D status in populations worldwide , 2013, British Journal of Nutrition.
[32] R. Gama,et al. Vitamin D: a negative acute phase reactant , 2013, Journal of Clinical Pathology.
[33] C. Cooper,et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) , 2013, Current medical research and opinion.
[34] D. Viswanath,et al. Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.
[35] M. Kiely,et al. Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. , 2012, The American journal of clinical nutrition.
[36] A. Díez-Pérez,et al. Risk factors for prediction of inadequate response to antiresorptives , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] W. Willett,et al. Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] C. Cooper,et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2008, Osteoporosis International.
[39] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[40] I. Bhan,et al. Vitamin D–Binding Protein Modifies the Vitamin D–Bone Mineral Density Relationship , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] M. Drezner,et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. , 2011, The Journal of clinical endocrinology and metabolism.
[42] F. Leblond,et al. Reduced hepatic synthesis of calcidiol in uremia. , 2010, Journal of the American Society of Nephrology : JASN.
[43] S. Ish-shalom,et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. , 2008, The Journal of clinical endocrinology and metabolism.
[44] B. Hollis,et al. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. , 2008, The American journal of clinical nutrition.
[45] P. Garnero,et al. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. , 2008, Clinical chemistry.
[46] S. Adami,et al. [The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. , 2005 .
[47] D. Felsenberg,et al. Performance evaluation of automated assays for β-CrossLaps, N-MID-Osteocalcin and intact parathyroidhormone (BIOROSE Multicenter Study) , 2004, Clinical chemistry and laboratory medicine.
[48] S. Gonnelli,et al. Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women , 2002, European Journal of Clinical Nutrition.